Cardinal Health Receives Moderate Buy Rating from Analysts

Got story updates? Submit your updates here. ›

Cardinal Health, Inc. (NYSE:CAH) has been assigned an average recommendation of "Moderate Buy" from the seventeen ratings firms currently covering the company, according to MarketBeat. Two analysts have rated the stock as a hold, fourteen have issued buy recommendations, and one has given it a strong buy rating. The average 12-month price target among brokers is $244.33.

Why it matters

Cardinal Health is a major player in the healthcare supply chain and distribution industry, providing key services to hospitals, pharmacies, and other medical providers. The consensus "Moderate Buy" rating from analysts signals confidence in the company's performance and growth potential, which could impact investor sentiment and the stock price.

The details

The analysts' recommendations cover a range of perspectives on Cardinal Health's outlook. Citigroup upgraded the stock from neutral to buy and raised the price target, while Wall Street Zen downgraded it from strong buy to buy. Other firms like Barclays, Leerink Partners, and Argus have issued buy or outperform ratings with increased price targets, reflecting an overall positive view on the company's prospects.

• Cardinal Health reported its latest quarterly earnings on February 5, 2026.
• The company's next quarterly report is expected in early May 2026.

What’s next

Investors will be closely watching Cardinal Health's upcoming quarterly earnings report in early May 2026 for any updates on the company's financial performance and outlook.